GH Research is trading 0.3% up at $27.63, with no clear company-specific catalyst identified for September 16.

  • It closed at $27.55 on September 15, 2026.
  • The latest disclosed item is a September 11 announcement about investor meetings at the Morgan Stanley Global Healthcare Conference, scheduled for September 14–16; it does not directly explain the pre-market move.
  • Broader futures are modestly higher ahead of U.S. retail-sales data and the FOMC statement.